Koers Syneos Health, Inc.
Aandelen
SYNH
US87166B1026
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 01-07-23 |
Michael Brooks
COO | Chief Operating Officer | 50 | 14-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 28-09-23 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
James Dimitri
BRD | Director/Board Member | - | 28-09-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.82% | 0 M€ | -.--% | ||
0.77% | 0 M€ | +8,27% | ||
0.50% | 0 M€ | 0,00% | - | |
0.36% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,74% | 46,81 mld. | |
-0,97% | 41,37 mld. | |
+47,07% | 41,29 mld. | |
-3,52% | 28,87 mld. | |
+11,12% | 26,06 mld. | |
-19,37% | 19,13 mld. | |
+31,18% | 12,39 mld. | |
-0,04% | 12,08 mld. | |
+0,39% | 11,96 mld. |